Consideraciones sobre la vacunación contra la hepatitis A / Considerations about hepatitis A vaccination
Rev. méd. Chile
;
124(3): 362-6, mar. 1996.
Artículo
en Español
| LILACS
| ID: lil-173343
ABSTRACT
Hepatitis A is endemic in Chile with rates of 100 cases per 100.000 inhabitants/years, figure that triplicates in school age children. Its social impact justifies educational and other public work measures to control it. Vaccines are an effective but expensive control resourse. The vaccine elaborated with the inactive HM 175 strain, recently licensed in Chile, is immunogenic, effective and well tolerated in adults and children over 3 years old. Its main indication is for voyagers to endemic areas and patients with chronic liver diseases. In Chile, its individual prescription requires the assessment of patient's individual risk and basal immunological status. Its massive application requires a better knowledge of hepatitis A geographical distribution, age of infection and cost benefit ratios
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Vacunas contra Hepatitis Viral
/
Hepatitis A
Tipo de estudio:
Estudio de etiología
/
Factores de riesgo
Límite:
Humanos
Idioma:
Español
Revista:
Rev. méd. Chile
Asunto de la revista:
Medicina
Año:
1996
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS